Viscosupplementation for osteoarthritis of the knee: A systematic review and meta-analysis

Annals of Internal Medicine

Volumn 157, Issue 3, 2012, Pages 180-191

  Rutjes, Anne W S ^a   Jüni, Peter ^a   da Costa, Bruno R ^a   Trelle, Sven ^a   Nüesch, Eveline ^a   Reichenbach, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

ANALGESIA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; META ANALYSIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VISCOSUPPLEMENTATION;

EID: 84864540649     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-3-201208070-00473     Document Type: Review

References (132)

1. Murray CJL, Lopez AD, eds. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge: Harvard School of Public Health, on behalf of the World Health Organization; 1996. (Global Burden of Disease and Injury Series, Vol. 1).
2. Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal antiinflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol. 1995;141:539-45. [PMID: 7900721]
3. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086. [PMID: 21224324]
4. Brandt KD, Smith GN Jr, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum. 2000;43:1192-203. [PMID: 10857778]
5. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3-9. [PMID: 8410881]
6. Campbell J, Bellamy N, Gee T. Differences between systematic reviews/metaanalyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage. 2007;15:1424-36. [PMID: 17448701]
7. Rutjes AW, Nüesch E, Sterchi R, Kalichman L, Hendriks E, Osiri M, et al. Transcutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database Syst Rev. 2009:CD002823. [PMID: 19821296]
8. Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N, Bloch DA, et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage. 1996;4:217-43. [PMID: 11048620]
9. Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M, et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage. 2004;12:389-99. [PMID: 15094138]
10. Jüni P, Reichenbach S, Dieppe P. Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol. 2006;20:721-40. [PMID: 16979535]
11. Reichenbach S, Sterchi R, Scherer M, Trelle S, Bürgi E, Bürgi U, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007;146:580-90. [PMID: 17438317]
12. Reichenbach S, Blank S, Rutjes AW, Shang A, King EA, Dieppe PA, et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum. 2007;57:1410-8. [PMID: 18050181]
13. European Commission. Guidelines on Medical Devices. Clinical Investigations: Serious Adverse Event Reporting Under Directives 90/385/EEC and 93/ 42/EEC. Brussels, Belgium: European Commission; 2010. Accessed at http://ec.europa.eu/health/medical-devices/files/meddev/2_7_3_en.pdf on 27 February 2012.
14. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 [updated March 2011]. Oxford, UK: The Cochrane Collaboration; 2011. Accessed at www.cochrane-handbook.org on 21 May 2012.
15. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ. 2001;323:42-6. [PMID: 11440947]
16. Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010;341:c4675. [PMID: 20847017]
17. Angst F, Aeschlimann A, Michel BA, Stucki G. Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J Rheumatol. 2002;29:131-8. [PMID: 11824949]
18. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001;45:384-91. [PMID: 11501727]
19. Eberle E, Ottillinger B. Clinically relevant change and clinically relevant difference in knee osteoarthritis. Osteoarthritis Cartilage. 1999;7:502-3. [PMID: 10489324]
20. Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8:283-91. [PMID: 15207508]
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. [PMID: 3802833]
22. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester, UK: J Wiley; 2004.
23. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54:1046-55. [PMID: 11576817]
24. Moreno SG, Sutton AJ, Turner EH, Abrams KR, Cooper NJ, Palmer TM, et al. Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications. BMJ. 2009;339:b2981. [PMID: 19666685]
25. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contourenhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61:991-6. [PMID: 18538991]
26. Palmer TM, Peters JL, Sutton AJ, Moreno SG. Contour-enhanced funnel plots for meta-analysis. Stata J. 2008;8:242-54.
27. Shang A, Huwiler-Müntener K, Nartey L, Jüni P, Dorig S, Sterne JA, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet. 2005;366:726-32. [PMID: 16125589]
28. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta-analyses of osteoarthritis trials: metaepidemiological study. BMJ. 2010;341:c3515. [PMID: 20639294]
29. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34. [PMID: 9310563]
30. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999;18:2693-708. [PMID: 10521860]
31. Royston P, Sauerbrei W. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials. Stat Med. 2004;23:2509-25. [PMID: 15287081]
32. Anika Therapeutics. Confidentially obtained report. Bedford, MA: Anika Therapeutics; 2000.
33. Anika Therapeutics. Confidentially obtained report. Bedford, MA: Anika Therapeutics; 2001.
34. Genzyme Biomaterials. Confidentially obtained report. Cambridge, MA: Genzyme Biomaterials; 2005.
35. Personal communication (Rydell, 1972) described in: Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol (Paris). 1974;22:731-6. [PMID: 4614175]
36. Weiss C, Balazs EA, St Onge R, Denlinger JL. Clinical studies of the intra-articular injections of Healon (sodium hyaluronate) in the treatment of osteoarthritis of human knees. Semin Arthritis Rheum. 1981;11(Suppl 1):143-4.
37. Shichikawa K, Igarashi M, Sugawara S, Iwasaki Y. Clinical evaluation of high molecular weight sodium hyaluronate (SPH) on osteoarthritis of the knee-a multi-center well controlled comparative study. Jpn J Clin Pharmacol Therapeut. 1983;14:545-58.
38. Shichikawa K, Maeda A, Ogawa N. [Clinical evaluation of sodium hyaluronate in the treatment of osteoarthritis of the knee]. Ryumachi. 1983;23:280-90. [PMID: 6364389]
39. Bragantini A, Cassini M, de Bastiani G, Perbellini A. Controlled singleblind trial of intra-articularly injected hyaluronic acid (Hyalgan) in osteo-arthritis of the knee. Clin Trials J. 1987;24:333-40.
40. Grecomoro G, Martorana U, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica. 1987;5:137-41. [PMID: 3310017]
41. Dixon AS, Jacoby RK, Berry H, Hamilton EB. Clinical trial of intraarticular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin. 1988;11:205-13. [PMID: 3063436]
42. Ghirardini M, Betelemme L, Fatti F. Impiego intraarticolare di acido ialuronico estrattivo de orgoteina sia separatamente che in associazione in pazienti affetti da gonartrosi in fase sinovitica [Abstract]. Reumatismo. 1990;42:132.
43. Russell IJ, Michalek JE, Lawrence VA, Lessard JA, Briggs BT, May GS. A randomized, placebo (PL) and no-intervention (NI) controlled, trial of intraarticular (IA) 1% sodium hyaluronate (HA) in the treatment of knee osteoarthritis (OA) [Abstract B94]. Arthritis Rheum. 1992;35(Suppl):S132.
44. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebocontrolled trial. Osteoarthritis Cartilage. 1993;1:97-103. [PMID: 8886085]
45. Isdale AH, Hordon LD, Bird HA, Wright V. A controlled comparison of intra-articular Healon (hyaluronate), triamcinolone and saline in osteoarthritis of the knee [Abstract 118]. Br J Rheumatol. 1993;32(Suppl 1):61.
46. Moreland LW, Arnold WJ, Saway A, Savory C, Sikes D. Efficacy and safety of intra-articular hylan G-F 20 (Synvisc), a viscoelastic derivative of hyaluronan, in patients with osteoarthritis of the knee [Abstract]. Arthritis Rheum. 1993; 36(Suppl 9):165.
47. Pedersen PB. Intra-articular hyaluronic acid (HA) in the treatment of osteoarthritis (OA) of the knee [Abstract]. Osteoarthritis Cartilage. 1993;1:70.
48. Puhl W, Bernau A, Greiling H, Köpcke W, Pförringer W, Steck KJ, et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage. 1993;1:233-41. [PMID: 15449510]
49. Cohen MA, Shiroky JB, Ballachey ML, Neville C, Esdaile JM. Doubleblind randomized trial of intra-articular (I/A) hyaluronate in the treatment of osteoarthritis of the knee [Abstract 62]. Arthritis Rheum. 1994;37(Suppl 6):R31.
50. Creamer P, Sharif M, George E, Meadows K, Cushnaghan J, Shinmei M, et al. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage. 1994;2:133-40. [PMID: 11548229]
51. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis. 1994;53:529-34. [PMID: 7944639]
52. Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res Clin Exp. 1994;55: 220-32.
53. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage. 1995;3:213-25. [PMID: 8689457]
54. Carrabba M, Paresce E, Angelini M, Re KA, Torchiana EEM, Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm. 1995;15:25-31.
55. Corrado EM, Peluso GF, Gigliotti S, De DC, Palmieri D, Savoia N, et al. The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm. 1995;15:47-56.
56. Formiguera Sala S, Esteve de Miguel R. Intra-articular hyaluronic acid in the treatment osteoarthritis of the knee: a short term study. Eur J Rheumatol Inflamm. 1995;15:33-8.
57. Guler M, Kuran B, Parlar D, Guler M, Saglam H, Yapici S, et al. Clinical trial of intra-articular injection of hyaluronic acid in patients with osteoarthritis of the knee [Abstract]. Presented at X National Rheumatology Congress, Pamukkale-Denizli, Turkey, 29 October-3 November 1996.
58. Lohmander LS, Dalén N, Englund G, Hämäläinen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis. 1996;55:424-31. [PMID: 8774159]
59. Graf von der Schulenburg JM, Allhoff PG. Cost-effectiveness and quality of life of treatment of gonarthrosis with hyaluronic acid [Abstract 187]. Rheumatol Eur. 1997;26(Suppl 2):191.
60. Kalay S. The effectiveness of intra-articular hyaluronic acid treatment in primary gonarthrosis [Specialization thesis]. Ankara, Turkey: Ministry of Health, Republic of Turkey; 1997.
61. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage. 1997;5:153-60. [PMID: 9219678]
62. Schneider U, Miltner O, Graf J, Thomsen M, Niethard FU. [Mechanism of action of hyaluronic acid in gonarthrosis of both knee joints in a right/left comparison. Study with dynamometry, oxygen partial pressure, temperature and Lequesne score]. Z Orthop Ihre Grenzgeb. 1997;135:341-7. [PMID: 9381772]
63. Wu JJ, Shih LY, Hsu HC, Chen TH. The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei). 1997;59:99-106. [PMID: 9175299]
64. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25:2203-12. [PMID: 9818665]
65. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther. 1998;20:410-23. [PMID: 9663358]
66. Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford). 1999;38:602-7. [PMID: 10461471]
67. Payne MW, Petrella RJ. Viscosupplementation effect on proprioception in the osteoarthritic knee. Arch Phys Med Rehabil. 2000;81:598-603. [PMID: 10807098]
68. Renklitepe N, Atalay E. The effect of intra-articular sodium hyaluronate therapy in knee osteoarthritis [Abstract 328]. Ann Rheum Dis. 2000;59(Suppl):142.
69. Ardiç F, Bolulu D, Topuz O, Cubukçu S. Efficacy of intra-articular hyaluronic acid injections in knee osteoarthritis [Abstract 75]. Ann Rheum Dis. 2001; 60(Suppl 1):232.
70. Bunyaratavej N, Chan KM, Subramanian N. Treatment of painful osteoarthritis of the knee with hyaluronic acid. Results of a multicenter Asian study. J Med Assoc Thai. 2001;84 Suppl 2:S576-81. [PMID: 11853284]
71. Caracuel MA, Muñoz-Villanueva MC, Escudero A, Veroz R, Frias G, Vacas J, et al. Effects of joint lavage and hyaluronic acid infiltration in patients with osteoarthritis of the knee [Abstract 91]. Ann Rheum Dis. 2001;60(Suppl):236.
72. Dickson DJ, Hosie G, English JR; Primary Care Rheumatology Society OA Knee Study Group. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Research. 2001;4:41-52.
73. Groppa LG, Moshneaga M. Studying of the efficiency of the synvisk in osteoartrosis [Abstract 144]. Ann Rheum Dis. 2001;60(Suppl 1):230.
74. Seikagaku Corporation. Summary of safety and effectiveness data: Sodium hyaluronate. Bethesda, MD: U.S. Food and Drug Administration; 2001. Accessed at www.accessdata.fda.gov/cdrh_docs/pdf/P980044b.pdf on 27 February 2012.
75. Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19:265-70. [PMID: 11407078]
76. Bütün B, Kaçar C, Evcik D. Intra-articular injection of sodium hyaluronate in the treatment of knee osteoarthritis. Romatizma. 2002;17:31-8.
77. Cogalgil S, Hatipoglu F. The effects of intra-articular sodium-hyaluronan in patients with gonarthrosis treated with physical therapy [Abstract 282]. Presented at the European League Against Rheumatism, 3rd Annual European Congress of Rheumatology, Stockholm, Sweden, 12-15 June 2002. Accessed at www.abstracts2view.com/eular/view.php?nu_EULAR2L1 _2002AB0282&terms_ on 21 May 2012.
78. Hizmetli S, Kocagil S, Kaptanoglu E, Elden H, Nacitarhan V. The efficacy and safety of intra-articular hyaluronic acid in osteoarthritis of the knee: a prospective, double-blind trial. Pamphlet provided at the European League Against Rheumatism, 3rd Annual European Congress of Rheumatology, Stockholm, Sweden, 12-15 June 2002.
79. Karlsson J, Sjögren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford). 2002;41:1240-8. [PMID: 12421996]
80. Miltner O, Schneider U, Siebert CH, Niedhart C, Niethard FU. Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis-a prospective clinical trial. Osteoarthritis Cartilage. 2002;10:680-6. [PMID: 12202120]
81. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2002;162: 292-8. [PMID: 11822921]
82. Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, et al; Canadian Knee OA Study Group. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage. 2002;10:506-17. [PMID: 12127830]
83. Saravanan V, Morgan T, Stobbs D, Daymond TJ. Inflammatory effusion after viscosupplementation with Hylan G-F 20 [Abstract 336]. Rheumatology. 2002;41(Suppl 1):121.
84. Bayramoǧlu M, Karataş M, Cetin N, Akman N, Sözay S, Dilek A. Comparison of two different viscosupplements in knee osteoarthritis-a pilot study. Clin Rheumatol. 2003;22:118-22. [PMID: 12740676]
85. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003;57:467-74. [PMID: 12918884]
86. Kahan A, Lleu PL, Salin L. Prospective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine. 2003;70:276-81. [PMID: 12951310]
87. Tetik S, Ones K, Tetik C. Efficacy of intra-articular Hylan G-F 20 on osteoarthritis of the knee. The Pain Clinic. 2003;15:459-66.
88. Tsai CL, Chang CC, Chen SC, Beinat L, Piva S. Treatment of knee osteoarthritis in Asian population with an intra-articular hyaluronan of MW500-730 KDa [Abstract P333]. Osteoarthritis Cartilage. 2003;11(Suppl A):119.
89. Altman RD, Akermark C, Beaulieu AD, Schnitzer T; Durolane International Study Group. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2004;12:642-9. [PMID: 15262244]
90. Day R, Brooks P, Conaghan PG, Petersen M; Multicenter Trial Group. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31:775-82. [PMID: 15088306]
91. Groppa L, Golubciuc S, Vremis L, Dutca L, Sincari L. The efficacy of combined chondroprotective treatment in the osteoarthritis of the knee [Abstract 415]. Zurich, Switzerland: European League Against Rheumatism; 2004. Accessed at www.abstracts2view.com/eular/view.php?nu_EULAR04L1 _2004FRI0415&terms on 27 February 2012.
92. Pham T, Le Henanff A, Ravaud P, Dieppe P, Paolozzi L, Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis. 2004;63:1611-7. [PMID: 15331394]
93. Wu HB, Du JY, Yang SH, Shao ZW, Xiong XQ. [Evaluation on the effects of hyaluronan combined with different dosages of celecoxib for relieving pain and ankylosis induced by knee osteoarthritis]. Zhongguo Linchuang Kangfu. 2004;8: 5491-3.
94. Cubukçu D, Ardiç F, Karabulut N, Topuz O. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol. 2005;24:336-41. [PMID: 15599642]
95. Huang MH, Yang RC, Lee CL, Chen TW, Wang MC. Preliminary results of integrated therapy for patients with knee osteoarthritis. Arthritis Rheum. 2005;53:812-20. [PMID: 16342083]
96. Neustadt D, Caldwell J, Bell M, Wade J, Gimbel J. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol. 2005;32:1928-36. [PMID: 16206349]
97. Sezgin M, Demirel AC, Karaca C, Ortancil O, Ulkar GB, Kanik A, et al. Does hyaluronan affect inflammatory cytokines in knee osteoarthritis? Rheumatol Int. 2005;25:264-9. [PMID: 14999424]
98. Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int. 2006;26:325-30. [PMID: 15959784]
99. Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006;33:951-6. [PMID: 16652426]
100. Atay T, Aslan A, Baydar ML, Ceylan B, Baykal B, Kirdemir V. [The efficacy of low-and high-molecular-weight hyaluronic acid applications after arthroscopic debridement in patients with osteoarthritis of the knee]. Acta Orthop Traumatol Turc. 2008;42:228-33. [PMID: 19060515]
101. Blanco FJ, Fernández-Sueiro JL, Pinto-Tasende JA, Fernández-López JC, Ramallal M, Freire A, et al. Intra-articular hyaluronan treatment of patients with knee osteoarthritis waiting for replacement surgery. Open Arthritis J. 2008;1:1-7.
102. Heybeli N, Doral MN, Atay OA, Leblebicioǧlu G, Uzümcügil A. [Intraarticular sodium hyaluronate injections after arthroscopic debridement for osteoarthritis of the knee: a prospective, randomized, controlled study]. Acta Orthop Traumatol Turc. 2008;42:221-7. [PMID: 19060514]
103. Lundsgaard C, Dufour N, Fallentin E, Winkel P, Gluud C. Intra-articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial. Scand J Rheumatol. 2008;37:142-50. [PMID: 18415773]
104. Petrella RJ, Cogliano A, Decaria J. Combining two hyaluronic acids in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Clin Rheumatol. 2008;27:975-81. [PMID: 18204873]
105. Altman RD, Rosen JE, Bloch DA, Hatoum HT, Korner P. A doubleblind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an openlabel safety extension (the FLEXX trial). Semin Arthritis Rheum. 2009;39:1-9. [PMID: 19539353]
106. Baltzer AW, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage. 2009;17:152-60. [PMID: 18674932]
107. Baraf HS, Strand V, Hosokawa H, Akahane O, Lim S, Yaguchi M. Effectiveness and safety of a single intraarticular injection of gel-200, a new crosslinked formulation of hyaluronic acid [HA] in the treatment of symptomatic osteoarthritis [OA] of the knee [Abstract 326]. Osteoarthritis Cartilage. 2009; 17(Suppl 1):S174.
108. Diracoglu D, Vural M, Baskent A, Dikici F, Aksoy C. The effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis. J Back Musculoskelet Rehabil. 2009;22:1-9. [PMID: 20023357]
109. Petrella RJ, Decaria JE, Wolfe D, Chesworth B, Shapiro S, Montero-Odasso M. The effect of hyaluronic acid on gait in knee osteoarthritis patients: preliminary results for a randomized, double-blind, placebo controlled study [Abstract 375]. Ann Rheum Dis. 2009;68(Suppl 3):479.
110. Chevalier X, Jerosch J, Goupille P, van Dijk N, Luyten FP, Scott DL, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis. 2010;69:113-9. [PMID: 19304567]
111. Jørgensen A, Stengaard-Pedersen K, Simonsen O, Pfeiffer-Jensen M, Eriksen C, Bliddal H, et al. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis. 2010;69:1097-102. [PMID: 20447955]
112. Kosuwon W, Sirichatiwapee W, Visanuyotin T, Jeeravipoolvarn P, Laupattarakasem W. An efficacy study on cartilage volume by MRI findings in patient with knee osteoarthritis between 25 mg of sodium hyaluronate (2.5 ml) to placebo [Abstract 370]. Ann Rheum Dis. 2010;69(Suppl 3):267.
113. Kul-Panza E, Berker N. Is hyaluronate sodium effective in the management of knee osteoarthritis? A placebo-controlled double-blind study. Minerva Med. 2010;101:63-72. [PMID: 20467406]
114. Pavelka K, Niethard FU, Giordan N. A multicentre, international, double blind, randomized, placebo-controlled study to assess the efficacy and safety of 2 different regimens of HYADD4-G in knee osteoarthritis [Abstract 326]. Osteoarthritis Cartilage. 2010;18(Suppl 2):S144.
115. Sanofi-Aventis. TREAD-20: Trial of Hyalgan three injection-regimen for the treatment of knee pain due to osteoarthritis [clinical trial]. Accessed at http: //clinicaltrials.gov/ct2/show/NCT00130468 on 21 February 2012.
116. Huang TL, Chang CC, Lee CH, Chen SC, Lai CH, Tsai CL. Intraarticular injections of sodium hyaluronate (Hyalgan®) in osteoarthritis of the knee. a randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord. 2011;12:221. [PMID: 21978211]
117. Navarro-Sarabia F, Coronel P, Collantes E, Navarro FJ, de la Serna AR, Naranjo A, et al; AMELIA study group. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70:1957-62. [PMID: 21852252]
118. Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res. 2001:130-43. [PMID: 11302304].
119. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494-502. [PMID: 13498604]
120. Nüesch E, Jüni P. Commentary: Which meta-analyses are conclusive? Int J Epidemiol. 2009;38:298-303. [PMID: 19074491]
121. Sterne JA, Gavaghan D, Egger M. Publication and related bias in metaanalysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53:1119-29. [PMID: 11106885]
122. Pelletier JP, Hochberg MC, du Souich P, Kahan A, Michel BA. Glucosamine and osteoarthritis. Effect size is encouraging [Letter]. BMJ. 2010;341: c6328. [PMID: 21062884]
123. Ruyssen-Witrand A, Tubach F, Ravaud P. Systematic review reveals heterogeneity in definition of a clinically relevant difference in pain. J Clin Epidemiol. 2011;64:463-70. [PMID: 21109400]
124. Nüesch E, Reichenbach S, Trelle S, Rutjes AW, Liewald K, Sterchi R, et al. The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. Arthritis Rheum. 2009;61:1633-41. [PMID: 19950329]
125. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Bürgi E, Scherer M, et al. The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ. 2009;339:b3244. [PMID: 19736281]
126. Modawal A, Ferrer M, Choi HK, Castle JA. Hyaluronic acid injections relieve knee pain. J Fam Pract. 2005;54:758-67. [PMID: 16144589]
127. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2004;86-A:538-45. [PMID: 14996880]
128. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006:CD005321. [PMID: 16625635]
129. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Müllner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ. 2005;172:1039-43. [PMID: 15824412]
130. Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA. 2003;290:3115-21. [PMID: 14679274]
131. Medina JM, Thomas A, Denegar CR. Knee osteoarthritis: should your patient opt for hyaluronic acid injection? J Fam Pract. 2006;55:669-75. [PMID: 16882439]
132. Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis-meta-analysis. Osteoarthritis Cartilage. 2011;19:611-9. [PMID: 21443958]